Literature DB >> 21559787

Physiological significance of P2X receptor-mediated vasoconstriction in five different types of arteries in rats.

Lu Li1, Zhen-Hua Jia, Chao Chen, Cong Wei, Jian-Ke Han, Yi-Ling Wu, Lei-Ming Ren.   

Abstract

P2X(1) receptors, the major subtype of P2X receptors in the vascular smooth muscle, are essential for α,β-methylene adenosine 5'-triphosphate (α,β-MeATP)-induced vasoconstriction. However, relative physiological significance of P2X(1) receptor-regulated vasoconstriction in the different types of arteries in the rat is not clear as compared with α(1)-adrenoceptor-regulated vasoconstriction. In the present study, we found that vasoconstrictive responses to noncumulative administration of α,β-MeATP in the rat isolated mesenteric arteries were significantly smaller than those to single concentration administration of α,β-MeATP. Therefore, we firstly reported the characteristic of α,β-MeATP-regulated vasoconstrictions in rat tail, internal carotid, pulmonary, mesenteric arteries, and aorta using single concentration administration of α,β-MeATP. The rank order of maximal vasoconstrictions for α,β-MeATP (E (max·α,β-MeATP)) was the same as that of maximal vasoconstrictions for noradrenaline (E (max·NA)) in the internal carotid, pulmonary, mesenteric arteries, and aorta. Moreover, the value of (E (max·α,β-MeATP)/E (max·KCl))/(E (max·NA)/E (max·KCl)) was 0.4 in each of the four arteries, but it was 0.8 in the tail artery. In conclusion, P2X(1) receptor-mediated vasoconstrictions are equally important in rat internal carotid, pulmonary, mesenteric arteries, and aorta, but much greater in the tail artery, suggesting its special role in physiological function.

Entities:  

Year:  2011        PMID: 21559787      PMCID: PMC3146638          DOI: 10.1007/s11302-011-9226-y

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  40 in total

1.  Changes in purinergic signalling in developing and ageing rat tail artery: importance for temperature control.

Authors:  Anna Wallace; Gillian E Knight; Tim Cowen; Geoffrey Burnstock
Journal:  Neuropharmacology       Date:  2005-10-13       Impact factor: 5.250

2.  P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries.

Authors:  Catherine Vial; Richard J Evans
Journal:  Mol Pharmacol       Date:  2002-12       Impact factor: 4.436

3.  A neuromodulatory role for neuronal nitric oxide in the rabbit renal artery.

Authors:  A J Vials; R Crowe; G Burnstock
Journal:  Br J Pharmacol       Date:  1997-05       Impact factor: 8.739

4.  Involvement of Ca2+ sensitization in ropivacaine-induced contraction of rat aortic smooth muscle.

Authors:  Jingui Yu; Yasuyuki Tokinaga; Toshiyuki Kuriyama; Nobuhiko Uematsu; Kazuhiro Mizumoto; Yoshio Hatano
Journal:  Anesthesiology       Date:  2005-09       Impact factor: 7.892

5.  Heterogenous vascular effects of AP5A in different rat resistance arteries are due to heterogenous distribution of P2X and P2Y(1) purinoceptors.

Authors:  M Steinmetz; S Bierer; P Hollah; K H Rahn; E Schlatter
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

6.  Non-adrenergic inhibition at prejunctional sites by agmatine of purinergic vasoconstriction in rabbit saphenous artery.

Authors:  Ding Zhao; Lei-Ming Ren
Journal:  Neuropharmacology       Date:  2005-03       Impact factor: 5.250

7.  Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide.

Authors:  A L García-Villalón; J L Garcia; N Fernández; L Monge; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

8.  Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats.

Authors:  J J Galligan; M C Hess; S B Miller; G D Fink
Journal:  J Pharmacol Exp Ther       Date:  2001-02       Impact factor: 4.030

9.  Effect of heating on vascular reactivity in rat mesenteric arteries.

Authors:  M P Massett; S J Lewis; J N Bates; K C Kregel
Journal:  J Appl Physiol (1985)       Date:  1998-08

10.  New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor.

Authors:  A J Brake; M J Wagenbach; D Julius
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

View more
  6 in total

1.  Exhaustive swimming differentially inhibits P2X1 receptor- and α1-adrenoceptor-mediated vasoconstriction in isolated rat arteries.

Authors:  Lu Li; Tao Wu; Cong Wei; Jian-ke Han; Zhen-hua Jia; Yi-ling Wu; Lei-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  (-)Doxazosin is a necessary component for the hypotensive effect of (±)doxazosin during long-term administration in conscious rats.

Authors:  Jing Zhao; De-zhi Kong; Qing Li; Ya-qin Zhen; Miao Wang; Yan Zhao; Dong-kai Wang; Lei-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2013-12-16       Impact factor: 6.150

3.  Interception of the endotoxin-induced arterial hyporeactivity to vasoconstrictors.

Authors:  Shuang Zhang; Ningren Cui; Shanshan Li; Lei Guo; Yang Wu; Daling Zhu; Chun Jiang
Journal:  Vascul Pharmacol       Date:  2014-04-30       Impact factor: 5.773

4.  Differential effects of short- and long-term bupivacaine treatment on α1-adrenoceptor-mediated contraction of isolated rat aorta rings and the reversal effect of lipid emulsion.

Authors:  Hao Guo; He-fei Zhang; Wen-qi Xu; Qian Du; Jing Zhao; Lei-ming Ren
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

5.  8-BuS-ATP derivatives as specific NTPDase1 inhibitors.

Authors:  Joanna Lecka; Irina Gillerman; Michel Fausther; Mabrouka Salem; Mercedes N Munkonda; Jean-Philippe Brosseau; Christine Cadot; Mireia Martín-Satué; Pedro d'Orléans-Juste; Eric Rousseau; Donald Poirier; Beat Künzli; Bilha Fischer; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

6.  Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1.

Authors:  Joanna Lecka; Michel Fausther; Beat Künzli; Jean Sévigny
Journal:  Mediators Inflamm       Date:  2014-08-11       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.